Guizhou Meiheyuan Biotechnology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Guizhou Meiheyuan Biotechnology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DORAMONE. The owner is based in Tongren.

Guanghui Community, Qinglong Street,

Tongren 565200 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DORAMONE
DORAMONE
Registered 2022

Trademark Classifications

Guizhou Meiheyuan Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Guizhou Meiheyuan Biotechnology Co., Ltd. have?

Guizhou Meiheyuan Biotechnology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guizhou Meiheyuan Biotechnology Co., Ltd. file in?

Guizhou Meiheyuan Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Guizhou Meiheyuan Biotechnology Co., Ltd.'s most well-known trademarks?

Guizhou Meiheyuan Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as DORAMONE. These are among 1 currently registered trademark in the portfolio.

What is Guizhou Meiheyuan Biotechnology Co., Ltd.'s trademark registration success rate?

Guizhou Meiheyuan Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.